Medidata and the University of Sydney’s NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia
Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering…
Max India Limited’s Rights Issue: 1.45 Times Oversubscription Signals Strong Investor Confidence
Max India Limited (MIL) has announced the successful closure of its Rights…
